Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment

被引：0
|
作者：
Merola, Joseph F. [1 ]
Chiou, Albert S. [2 ]
During, Emmanuel [2 ]
Costanzo, Antonio [3 ]
Foley, Peter [4 ]
Ardeleanu, Marius [5 ]
Wu, Jiangming [6 ]
Ozturk, Zafer E. [7 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Stanford Univ, Palo Alto, CA USA
[3] Humanitas Univ, Milan, Italy
[4] Skin Hlth Inst, Carlton, Vic, Australia
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, NJ USA
[7] Sanofi, Cambridge, MA USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
patient-reported outcomes; sleep; depression; anxiety; moderate-to-severe;
D O I：
10.1093/bjd/ljac140.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
335
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
    Awosika, Olabola
    Kim, Lori
    Mazhar, Momina
    Rengifo-Pardo, Monica
    Ehrlich, Alison
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 : 41 - 49
  • [42] Dupilumab treatment improved sleep quality in moderate-to-severe atopic dermatitis in children aged 6 months-5 years and their caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Marco, Ainara R.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E112 - E113
  • [43] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Wang, Fa-Ping
    Tang, Xiao-Ju
    Wei, Chuan-Qi
    Xu, Lin-Rui
    Mao, Hui
    Luo, Feng-Ming
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) : 190 - 198
  • [44] An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Deng, Sisi
    Wang, Huan
    Fu, Jiong
    Zhai, Zhifang
    Chen, Qiquan
    Song, Zhiqiang
    DERMATOLOGIC THERAPY, 2024, 2024
  • [45] Dupilumab provides sustained improvement of sleep disturbance in children ≥6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A. S.
    Wollenberg, A.
    Simpson, E. L.
    Beck, L. A.
    Chih-ho, Hong H.
    Marcoux, D.
    Bastian, M.
    Chen, Z.
    Levit, N. A.
    Bansal, A.
    Rossi, A. B.
    Chao, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 97 - 98
  • [46] Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
    SILVERBERG, Jonathan I.
    SIMPSON, Eric L.
    BOGUNIEWICZ, Mark
    DE BRUIN-WELLER, Marjolein S.
    FOLEY, Peter
    KATAOKA, Yoko
    BEGO-LE BAGOUSSE, Gaelle
    CHEN, Zhen
    SHUMEL, Brad
    CHAO, Jingdong
    ROSS, Ana B., I
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [47] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [48] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, S.
    Brunner, P. M.
    Garcet, S.
    Finney, R.
    Cohen, S. R.
    Oliva, M.
    Dutt, R.
    Fuentes-Duculan, J.
    Zheng, X.
    Li, X.
    Bonifacio, K. M.
    Kunjravia, N.
    Coats, I.
    Cueto, I.
    Gilleaudeau, P.
    Sullivan-Whalen, M.
    Suarez-Farinas, M.
    Krueger, J. G.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
  • [49] Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year COMMENT
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Simpson, Eric L.
    Chen, Zhen
    Ardeleanu, Marius
    Rossi, Ana B.
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 9 - 13
  • [50] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
    Zhang, Jianzhong
    Zhao, Yan
    Zhou, Qinghong
    Xu, Yuyu
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
12345